
Twist Bioscience Corporation: shareholders and insiders
Price
$116.35
November 18, 2026Market cap $7.9B
What Ploutos Investor adds for Twist Bioscience
Part of Ploutos Investor, €9.99 a month
- The full history: 10 fiscal years, from FY2017
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Insiders and their shares
Purchases and sales by officers and directors from Nov 19, 2025 to Nov 18, 2026, from their own Form 4 filings.
Bought on the market
–
nobody
Sold on the market
$153M
10 people
From Nov 19, 2025 to Nov 19, 2026, the days the chart shows. Change its range and the figures follow.
How the sales were made, as a share of their value
- Under a set plan79%
- The rest21%
By year
Insiders' open-market purchases (up) and sales (down), by value, since Nov 19, 2025, on a log scale: each gridline is ten times the last. From the SEC's quarterly data sets of Form 4 filings.
2026·no buys·sold $153M by 10 people
- 2025: no buys, sold $406.4K by 6 people
- 2026: no buys, sold $153M by 10 people
- Nov 16, 2026Dennis ChoSenior Vice President, Chief Legal Officer & Corporate SecretaryKind
- Nov 16, 2026Dennis ChoSenior Vice President, Chief Legal Officer & Corporate SecretaryKind
- Nov 16, 2026Patrick John FinnPresident and COOKind
- Nov 16, 2026Patrick John FinnPresident and COOKind
- Nov 16, 2026Paula GreenSVP of Human ResourcesKind
- Nov 16, 2026Paula GreenSVP of Human ResourcesKind
- Nov 16, 2026Emily M. LeproustChief Executive OfficerKind
- Nov 16, 2026Emily M. LeproustChief Executive OfficerKind
- Nov 16, 2026Robert F. WernerChief Accounting OfficerKind
- Nov 16, 2026Robert F. WernerChief Accounting OfficerKind
- Nov 16, 2026Adam LaponisChief Financial OfficerKind
- Nov 16, 2026Adam LaponisChief Financial OfficerKind
- Nov 12, 2026Dennis Choofficer (role written in the filing's remarks, not read)Kind
- Nov 12, 2026Emily M. LeproustChief Executive OfficerKind
- Nov 12, 2026Patrick John FinnPresident and COOKind
- Nov 12, 2026Adam LaponisChief Financial OfficerKind
- Nov 12, 2026Paula GreenSVP of Human ResourcesKind
- Nov 12, 2026Robert F. WernerChief Accounting OfficerKind
- Nov 3, 2026Dennis ChoSenior Vice President, Chief Legal Officer & Corporate SecretaryKind
- Nov 3, 2026Patrick John FinnPresident and COOKind
- Nov 3, 2026Emily M. LeproustChief Executive OfficerKind
- Nov 3, 2026Robert F. WernerChief Accounting OfficerKind
- Nov 3, 2026Paula GreenSVP of Human ResourcesKind
- Oct 23, 2026Patrick John FinnPresident and COOKind
- Oct 9, 2026Adam LaponisChief Financial OfficerKind
| Date | Person | Kind | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Nov 16, 2026 | Dennis ChoSenior Vice President, Chief Legal Officer & Corporate Secretary | 5,427 | $103.69 | $562.7K | Form 4 | |
| Nov 16, 2026 | Dennis ChoSenior Vice President, Chief Legal Officer & Corporate Secretary | 7,045 | – | – | Form 4 | |
| Nov 16, 2026 | Patrick John FinnPresident and COO | 12.8K | $103.69 | $1.3M | Form 4 | |
| Nov 16, 2026 | Patrick John FinnPresident and COO | 18.2K | – | – | Form 4 | |
| Nov 16, 2026 | Paula GreenSVP of Human Resources | 4,281 | $103.69 | $443.9K | Form 4 | |
| Nov 16, 2026 | Paula GreenSVP of Human Resources | 6,372 | – | – | Form 4 | |
| Nov 16, 2026 | Emily M. LeproustChief Executive Officer | 19.0K | $103.69 | $2.0M | Form 4 | |
| Nov 16, 2026 | Emily M. LeproustChief Executive Officer | 36.4K | – | – | Form 4 | |
| Nov 16, 2026 | Robert F. WernerChief Accounting Officer | 1,637 | $103.69 | $169.7K | Form 4 | |
| Nov 16, 2026 | Robert F. WernerChief Accounting Officer | 3,641 | – | – | Form 4 | |
| Nov 16, 2026 | Adam LaponisChief Financial Officer | 6,359 | $103.69 | $659.4K | Form 4 | |
| Nov 16, 2026 | Adam LaponisChief Financial Officer | 7,828 | – | – | Form 4 | |
| Nov 12, 2026 | Dennis Choofficer (role written in the filing's remarks, not read) | 22.8K | – | – | Form 4 | |
| Nov 12, 2026 | Emily M. LeproustChief Executive Officer | 95.4K | – | – | Form 4 | |
| Nov 12, 2026 | Patrick John FinnPresident and COO | 53.6K | – | – | Form 4 | |
| Nov 12, 2026 | Adam LaponisChief Financial Officer | 26.7K | – | – | Form 4 | |
| Nov 12, 2026 | Paula GreenSVP of Human Resources | 20.4K | – | – | Form 4 | |
| Nov 12, 2026 | Robert F. WernerChief Accounting Officer | 8,439 | – | – | Form 4 | |
| Nov 3, 2026 | Dennis ChoSenior Vice President, Chief Legal Officer & Corporate Secretary | 949 | $135.40 | $128.5K | Form 4 | |
| Nov 3, 2026 | Patrick John FinnPresident and COO | 2,565 | $135.40 | $347.3K | Form 4 | |
| Nov 3, 2026 | Emily M. LeproustChief Executive Officer | 4,573 | $135.40 | $619.2K | Form 4 | |
| Nov 3, 2026 | Robert F. WernerChief Accounting Officer | 148 | $135.40 | $20.0K | Form 4 | |
| Nov 3, 2026 | Paula GreenSVP of Human Resources | 1,007 | $135.40 | $136.3K | Form 4 | |
| Oct 23, 2026 | Patrick John FinnPresident and COO | 2,245 | $134.59 | $302.2K | Form 4 | |
| Oct 9, 2026 | Adam LaponisChief Financial Officer | 2,462 | $156.30 | $384.8K | Form 4 |
From the Form 4s insiders file with the SEC within two business days of each trade. Before May 26, 2026 the table lists open-market purchases and sales only (no grants, option exercises or tax withholding), from the SEC's quarterly data sets. The 10b5-1 mark comes from the form's own box (since April 2023) or from a footnote of the filing that names the plan, where there is one.
Insiders and their shares
Every buy and sale by TWST's officers and directors from 2018 up to November 18, 2025, 8 more calendar years
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 3 years.
and 3 more, back to 2018
Major holders (over 5%)
Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.
- FMRwith 1 more personShare of class14.4%
- BlackRock, Inc.Share of class8.30%
- T. Rowe Price Associates, Inc.Share of class5.80%
- ARK Investment Management LLCwith 1 more personShare of class5.11%
- Vanguard Capital ManagementShare of class5.05%
| Holder | Kind of stake | Share of class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| FMRwith 1 more person | 14.4% | 9.54M | Nov 5, 20263 filings since Aug 6, 2026 | 13G/A | |
| BlackRock, Inc. | 8.30% | 4.93M | Apr 17, 2025 | 13G/A | |
| T. Rowe Price Associates, Inc. | 5.80% | 3.63M | Aug 14, 2026 | 13G | |
| ARK Investment Management LLCwith 1 more person | 5.11% | 3.39M | Sep 8, 20266 filings since Jan 10, 2025 | 13G/A | |
| Vanguard Capital Management | 5.05% | 3.10M | Apr 30, 2026 | 13G |
Fell to 5% or less (6)
Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.
From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.
Well-known managers
Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.
- D.E. ShawIn the quarter+54%
- Point72 (Cohen)In the quarter
- Bridgewater (Dalio)In the quarter+345%
- Millennium Mgmt (Englander)In the quarter+43%
- Citadel Advisors (Griffin)In the quarter
- AQR CapitalIn the quarter+0.5%
| Manager | Shares | In the quarter | Value | % of their portfolio |
|---|---|---|---|---|
| D.E. Shaw | 1.83M | +54% | $353M | 0.22% |
| Point72 (Cohen) | 343.3K | $66M | 0.10% | |
| Bridgewater (Dalio) | 83.0K | +345% | $16M | 0.07% |
| Millennium Mgmt (Englander) | 495.3K | +43% | $96M | 0.07% |
| Citadel Advisors (Griffin) | – | – | 0.05% | |
| AQR Capital | 130.0K | +0.5% | $25M | 0.01% |
From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).
Short interest
How many of the company's shares have been sold borrowed and not yet bought back, twice a month.
On Oct 15, 2026, 15.0% of its shares outstanding were held short, -3.4% since the report before.
- Shares held short
- 10.21M
- 15.0%
- Since the report before10.57M on Sep 30, 2026
- -3.4%
- 2.8
- 3.62M
- More days to cover thanof 4,578 US-listed companies with enough volume
- 33%
- Report date
- Oct 15, 2026
- Shares held short
- Oct 31, 2023: Shares held short 14.96M
- Nov 15, 2023: Shares held short 15.02M
- Nov 30, 2023: Shares held short 15.41M
- Dec 15, 2023: Shares held short 14.49M
- Dec 29, 2023: Shares held short 11.62M
- Jan 12, 2024: Shares held short 12.56M
- Jan 31, 2024: Shares held short 12.33M
- Feb 15, 2024: Shares held short 12.36M
- Feb 29, 2024: Shares held short 12.40M
- Mar 15, 2024: Shares held short 12.01M
- Mar 28, 2024: Shares held short 12.26M
- Apr 15, 2024: Shares held short 12.25M
- Apr 30, 2024: Shares held short 11.93M
- May 15, 2024: Shares held short 10.70M
- May 31, 2024: Shares held short 11.09M
- Jun 14, 2024: Shares held short 10.85M
- Jun 28, 2024: Shares held short 9.57M
- Jul 15, 2024: Shares held short 9.53M
- Jul 31, 2024: Shares held short 9.87M
- Aug 15, 2024: Shares held short 9.21M
- Aug 30, 2024: Shares held short 9.38M
- Sep 13, 2024: Shares held short 8.94M
- Sep 30, 2024: Shares held short 8.70M
- Oct 15, 2024: Shares held short 8.83M
- Oct 31, 2024: Shares held short 9.02M
- Nov 15, 2024: Shares held short 8.75M
- Nov 29, 2024: Shares held short 9.65M
- Dec 13, 2024: Shares held short 8.95M
- Dec 31, 2024: Shares held short 8.70M
- Jan 15, 2025: Shares held short 9.18M
- Jan 31, 2025: Shares held short 8.64M
- Feb 14, 2025: Shares held short 9.22M
- Feb 28, 2025: Shares held short 9.30M
- Mar 14, 2025: Shares held short 8.83M
- Mar 31, 2025: Shares held short 9.59M
- Apr 15, 2025: Shares held short 9.73M
- Apr 30, 2025: Shares held short 9.96M
- May 15, 2025: Shares held short 10.62M
- May 30, 2025: Shares held short 10.68M
- Jun 13, 2025: Shares held short 10.31M
- Jun 30, 2025: Shares held short 11.03M
- Jul 15, 2025: Shares held short 10.75M
- Jul 31, 2025: Shares held short 10.44M
- Aug 15, 2025: Shares held short 11.01M
- Aug 29, 2025: Shares held short 10.23M
- Sep 15, 2025: Shares held short 12.82M
- Sep 30, 2025: Shares held short 12.98M
- Oct 15, 2025: Shares held short 10.86M
- Oct 31, 2025: Shares held short 10.55M
- Nov 14, 2025: Shares held short 10.90M
- Nov 28, 2025: Shares held short 12.75M
- Dec 15, 2025: Shares held short 13.74M
- Dec 31, 2025: Shares held short 14.26M
- Jan 15, 2026: Shares held short 12.50M
- Jan 30, 2026: Shares held short 12.17M
- Feb 13, 2026: Shares held short 13.01M
- Feb 27, 2026: Shares held short 12.73M
- Mar 13, 2026: Shares held short 12.86M
- Mar 31, 2026: Shares held short 14.15M
- Apr 15, 2026: Shares held short 14.52M
- Apr 30, 2026: Shares held short 13.91M
- May 15, 2026: Shares held short 16.58M
- May 29, 2026: Shares held short 14.90M
- Jun 15, 2026: Shares held short 17.66M
- Jun 30, 2026: Shares held short 13.95M
- Jul 15, 2026: Shares held short 14.12M
- Jul 31, 2026: Shares held short 14.08M
- Aug 14, 2026: Shares held short 14.11M
- Aug 31, 2026: Shares held short 12.07M
- Sep 15, 2026: Shares held short 12.51M
- Sep 30, 2026: Shares held short 10.57M
- Oct 15, 2026: Shares held short 10.21M
As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.
Short sales in daily trading57.9% of the shares in the last 14 sessions' reported trades were short sales.
In the last 14 sessions, 57.9% of the shares in the reported trades were short sales, against 49.0% in the 14 before.
- Last 14 sessionsOct 30, 2026 – Nov 18, 2026
- 57.9%
- The 14 beforeOct 12, 2026 – Oct 29, 2026
- 49.0%
- Change
- +8.9 pts
- Short sales a dayon average, of 1.08M shares
- 627.3K
- More than atof 3,656 US-listed companies, same days
- 77%
- Median of alleight in ten from 34.4% to 63.7%
- 50.3%
- Short sales
- Oct 12, 2026: Short sales 33.8%
- Oct 13, 2026: Short sales 32.7%
- Oct 14, 2026: Short sales 38.4%
- Oct 15, 2026: Short sales 39.6%
- Oct 16, 2026: Short sales 45.3%
- Oct 19, 2026: Short sales 61.5%
- Oct 20, 2026: Short sales 56.8%
- Oct 21, 2026: Short sales 52.1%
- Oct 22, 2026: Short sales 40.6%
- Oct 23, 2026: Short sales 57.3%
- Oct 26, 2026: Short sales 58.2%
- Oct 27, 2026: Short sales 62.6%
- Oct 28, 2026: Short sales 57.6%
- Oct 29, 2026: Short sales 64.5%
- Oct 30, 2026: Short sales 56.7%
- Nov 2, 2026: Short sales 44.7%
- Nov 3, 2026: Short sales 52.6%
- Nov 4, 2026: Short sales 62.9%
- Nov 5, 2026: Short sales 58.7%
- Nov 6, 2026: Short sales 60%
- Nov 9, 2026: Short sales 57.2%
- Nov 10, 2026: Short sales 55.5%
- Nov 11, 2026: Short sales 58.5%
- Nov 12, 2026: Short sales 68.8%
- Nov 13, 2026: Short sales 67.7%
- Nov 16, 2026: Short sales 44.3%
- Nov 17, 2026: Short sales 61.6%
- Nov 18, 2026: Short sales 54.5%
This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.
What the insiders hold
The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.
- Emily M. LeproustChief Executive OfficerDirectly670.9K
- William BanyaiSee RemarkDirectly345.2K
- Patrick John FinnPresident and COODirectly239.4K
- Paula GreenSVP of Human ResourcesDirectly128.1K
- Adam LaponisChief Financial OfficerDirectly126.3K
- Dennis ChoSee RemarksDirectly87.3K
- Robert F. WernerChief Accounting OfficerDirectly53.2K
- Melissa A. StarovasnikDirectorDirectly22.2K
- Robert ChessDirectorDirectly21.1K
- Jan JohannessenDirectorDirectly17.8K
- Katryn BlakeDirectorDirectly17.2K
| Person | Directly | Indirectly | After the trade of | Filing |
|---|---|---|---|---|
| Emily M. LeproustChief Executive Officer | 670.9K | – | Nov 16, 2026 | Form 4 |
| William BanyaiSee Remark | 345.2K | – | May 3, 2024 | Form 4 |
| Patrick John FinnPresident and COO | 239.4K | – | Nov 16, 2026 | Form 4 |
| Paula GreenSVP of Human Resources | 128.1K | – | Nov 16, 2026 | Form 4 |
| Adam LaponisChief Financial Officer | 126.3K | – | Nov 16, 2026 | Form 4 |
| Dennis ChoSee Remarks | 87.3K | – | Nov 16, 2026 | Form 4 |
| Robert F. WernerChief Accounting Officer | 53.2K | – | Nov 16, 2026 | Form 4 |
| Melissa A. StarovasnikDirector | 22.2K | – | May 28, 2026 | Form 4 |
| Robert ChessDirector | 21.1K | – | Aug 7, 2026 | Form 4 |
| Jan JohannessenDirector | 17.8K | – | May 12, 2026 | Form 4 |
| Katryn BlakeDirector | 17.2K | – | Aug 12, 2026 | Form 4 |
A lower bound: it counts only the 11 officers and directors with a market trade since Nov 20, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.
The ETFs that hold it
Which of the 345 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.
- ARKGARK Genomic Revolution ETFWeight in the fund7.73%
- ARKKARK Innovation ETFWeight in the fund3.31%
- XBIState Street(R) SPDR(R) S&P(R) Biotech ETFWeight in the fund1.41%
- LABUDirexion Daily S&P Biotech Bull 3X SharesWeight in the fund0.92%
- IBBiShares Biotechnology ETFWeight in the fund0.48%
- IWOiShares Russell 2000 Growth ETFWeight in the fund0.38%
- VTWOVanguard Russell 2000 Index FundWeight in the fund0.29%
- FESMFidelity Enhanced Small Cap Core ETFWeight in the fund0.26%
- IWMiShares Russell 2000 ETFWeight in the fund0.20%
- SCHASchwab U.S. Small-Cap ETFWeight in the fund0.19%
22 of the 345 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.
Institutional investors by quarter
Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.
- Managers
- Q3 2025: Managers 240
- Q4 2025: Managers 244
- Q1 2026: Managers 283
- Q2 2026: Managers 336
Institutional investors by quarter
The fund managers holding TWST, quarter by quarter, from Q4 2018 to Q2 2025, 27 more quarters
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 12 quarters.
Q2 2026: 336 managers held 76.39M shares, worth $7.9B. During the quarter 90 opened a position, 37 closed one, 96 added and 101 trimmed.
The largest holders, Q2 2026
- BlackRockIn the quarter+5.0%
- Artisan Partners Limited PartnershipIn the quarter-25%
- FMRIn the quarter+149%
- ARK Investment ManagementIn the quarter-28%
- Price T Rowe AssociatesIn the quarter×51.7
- State StreetIn the quarter-12%
- Vanguard Portfolio ManagementIn the quarter+6.6%
- Vanguard Capital ManagementIn the quarter+2.3%
- EdgePoint Investment GroupIn the quarter-53%
- William Blair Investment ManagementIn the quarter-59%
| Manager | Shares | In the quarter | Value |
|---|---|---|---|
| BlackRock | 5.83M | +5.0% | $600M |
| Artisan Partners Limited Partnership | 4.80M | -25% | $494M |
| FMR | 4.70M | +149% | $484M |
| ARK Investment Management | 4.55M | -28% | $468M |
| Price T Rowe Associates | 3.63M | ×51.7 | $374M |
| State Street | 3.23M | -12% | $333M |
| Vanguard Portfolio Management | 2.82M | +6.6% | $291M |
| Vanguard Capital Management | 2.70M | +2.3% | $278M |
| EdgePoint Investment Group | 2.52M | -53% | $259M |
| William Blair Investment Management | 2.17M | -59% | $224M |
From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.
Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.
The full analysis
What do Twist Bioscience's filings show?
Who buys and sells is one part of Twist Bioscience's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Have TWST's insiders bought or sold?
From May 26, 2026 to Nov 18, 2026 Twist Bioscience's insiders bought 0 and sold $139M of shares on the market. 81% of the sales were under set 10b5-1 plans.
Which well-known managers hold TWST?
6 of the managers we track held the shares on Sep 30, 2026. The largest position was D.E. Shaw's, worth $353M.
Is every insider transaction a purchase or a sale?
No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.